---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-003658"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2026-06-05T13:00:33+00:00"
generated_at: "2026-06-05T13:01:08.156384+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "medium"
source: SEC EDGAR
---

# BioNexus Gene Lab CEO urges Malaysia-China biotech co-development at May 21 forum

## Summary
- CEO Sam Tan spoke at the 2026 China-Malaysia Economic Cooperation Outlook Forum in Kuala Lumpur on May 21, 2026.
- Tan called for moving biotechnology collaboration beyond trade into co-development, clinical validation, and commercialization.
- Company highlighted its Fidelion Diagnostics Pte. Ltd. and VitaGuard MRD platform as a model for cross-border biotechnology structuring.
- Proposed pillars include accelerated clinical validation for precision oncology, specialized diagnostics infrastructure, and AI-integrated healthcare under regional data rules.
- No specific financial guidance, deal value, or other material quantitative changes disclosed.

## SEC filing metadata
- accession: 0001477932-26-003658
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2026-06-05T13:00:33+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: medium
- sec_items: 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793226003658/0001477932-26-003658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793226003658/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-003658
- JSON: https://secwatch.observer/filing/0001477932-26-003658.json
- Plain text: https://secwatch.observer/filing/0001477932-26-003658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.